SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy

被引:0
作者
Fei Li
Yong Xu
Ran-Lu Liu
机构
[1] The Second Hospital of Tianjin Medical University,Department of Urology, National Key Clinical Specialty of Urology
[2] Rugao City People’s Hospital,Department of Urology
来源
International Urology and Nephrology | 2019年 / 51卷
关键词
SAMD5; Biomarker; Recurrence; Prognosis; Prostatic neoplasms;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:443 / 451
页数:8
相关论文
共 65 条
  • [1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
  • [2] Ferlay J(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer Eur Urol 71 630-642
  • [3] Soerjomataram I(2018)Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis Cancer Manage Res 10 3125-3139
  • [4] Cornford P(2017)A pathology atlas of the human cancer transcriptome Science 9 e113606-31
  • [5] Bellmunt J(2018)Specific Eph receptor-cytoplasmic effector signaling mediated by SAM-SAM domain interactions elife 57 23-1025
  • [6] Bolla M(2014)Early growth response 4 is involved in cell proliferation of small cell lung cancer through transcriptional activation of its downstream genes PLoS ONE 163 1011-22
  • [7] Li D(2014)Prediction of response to preoperative chemoradiotherapy in rectal cancer by using reverse transcriptase polymerase chain reaction analysis of four genes Dis Colon Rectum 18 11-6
  • [8] Lv H(2015)The molecular taxonomy of primary prostate cancer Cell 6 1-W102
  • [9] Hao X(2010)Integrative genomic profiling of human prostate cancer Cancer Cell 45 W98-500
  • [10] Uhlen M(2004)ONCOMINE: a cancer microarray database and integrated data-mining platform Neoplasia 26 493-404